Subscribe

Text notifications

The latest news, dispensary sales, and new products!

We can't share everything on social (without getting flagged for cannabis content), so this is the best way to stay notified!

or Subscribe to Our Mailing List Subscribe to Texts

EMail Updates

* = Required

First Name *

Last Name *

Email Address *

zip *

Interested In:ALSCancerCrohn's DiseaseHIV/AIDSMultiple SclerosisParkinson's DiseaseSeizuresPainGeneral Info

Age Range:18 - 2425 - 3435 - 4445 - 5455+

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

stay in the know!

Staying up-to-date with news and announcements from Aliviar is simple.

Subscribe

Aliviar™ is not making specific therapeutic claims. The use of the term pharmaceutical, pharmaceutical grade, pharmaceutical dosage forms, etc. are indicative of the process by which new formulation products will be created with the intent of accurately identifying the active ingredients and the amount of each in each dosage form using best practices associated with traditional pharmacy formulations. Aliviar™ is seeking to take existing anecdotal evidence and through its own formulation process further identify which cannabis varieties and strains are best suited to which disease states.

Bud & Mary's NUO Product Feedback

Privacy Policy

Hello, are you at least 21?

By clicking '"I agree" and entering the website, I agree to be bound by the Terms of Service and Privacy policy.

I agree